HolderBook

SALARIUS PHARMACEUTICALS INC (SLRX)

Institutional ownership reported to the SEC as of Q1 2024, across 19 quarters.

12
Reporting holders
$87.0K
Reported value
0.0%
Held as options
-3
Holder change

Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.

Holders

FilerValueShares Their book Held Change
ARMISTICE CAPITAL, LLC$44.4K84,0000.00%4q-4.5%-$2.1K
HORIZON KINETICS ASSET MANAGEMENT LLC$16.4K31,0940.00%5qHELD
GEODE CAPITAL MANAGEMENT, LLC$13.1K24,7710.00%6qHELD
VANGUARD GROUP INC$7.7K14,5630.00%6qHELD
Tower Research Capital LLC (TRC)$4.5K8,4220.00%4q+2.9%
OSAIC HOLDINGS, INC.$7331,3870.00%6qHELD
MORGAN STANLEY$961800.00%6q+50.0%
WELLS FARGO & COMPANY/MN$16310.00%6q+3.3%
RENAISSANCE TECHNOLOGIES LLC$1528,2420.00%6q+6.8%
UBS Group AG$10180.00%6q-76.9%
BANK OF AMERICA CORP /DE/$8160.00%3qHELD
BlackRock Inc.$8150.00%6q-68.1%
FMR LLC$470.00%5q-78.8%

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q1 202412$87.0K164,5040340.0%
Q4 202315$152.8K236,3232350.0%
Q3 202313$210.8K320,1641510.0%
Q2 202313$290.5K194,9564230.0%
Q1 202310$148.1K77,4423220.0%
Q4 20226$60.9K39,8256000.0%
Q3 202219$671.0K3,442,0920260.0%
Q2 202223$859.0K4,095,8594740.0%
Q1 202225$1.4M3,641,7687240.0%
Q4 202124$2.6M5,310,2243750.0%
Q3 202125$6.8M6,709,2817540.0%
Q2 202129$10.8M10,166,4205990.0%
Q1 202131$22.8M15,480,651121310.0%
Q4 202024$4.0M4,421,0127530.0%
Q3 202017$630.0K746,9006220.0%
Q2 202013$637.0K483,0111330.0%
Q1 202016$533.0K781,7424320.0%
Q4 201912$909.0K241,1722140.0%
Q3 201912$1.4M256,17812000.0%